http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-111647076-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-565 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2317-76 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2333-165 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K39-42 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-56983 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N15-13 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-14 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-569 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K39-42 |
| filingDate | 2020-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2021-02-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-111647076-B |
| titleOfInvention | Neutralizing single-domain antibody for resisting novel coronavirus SARS-Cov-2 and application thereof |
| abstract | The invention relates to a neutralizing single-domain antibody for resisting novel coronavirus SARS-Cov-2 and application thereof. The antibody has at least one of a heavy chain CDR1, a heavy chain CDR2, and a heavy chain CDR 3. The antibody can be used for preparing a diagnostic reagent or a diagnostic kit, an antibody medicament or a pharmaceutical composition aiming at COVID-19. The invention obtains the neutralizing single-domain antibody for resisting novel coronavirus SARS-Cov-2 by phage display technology, the antibody can block the combination of SARS-Cov-2-RBD and ACE2 positive cells, has obvious virus neutralizing effect on SARS-Cov-2 pseudovirus, and provides effective alternative antibody medicine for preventing and treating COVID-19. |
| isCitedBy | http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023009028-A1 http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2023076881-A1 |
| priorityDate | 2020-04-27-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 182.